L12 - Anti-inflammatories - Antiheumatoids Flashcards
Rheumatoid arthritis affects?
Half a million-people affected by it in the UK
Affects 3x more women than men
Rheumatoid arthritis age of onset
40-60
There is a juvenile onset form
Rheumatoid arthritis risk factors
Environmental - smoking
Genetic
Rheumatoid arthritis symptoms
Inflammation of the synovium - increases risk of cardiovascular disease and therefore death
Swelling of the joints
Pain and stiffness
Poor sleep
Rheumatoid arthritis - cells and mediators that activate inflammation
Proinflammatory cytokines
Rheumatoid arthritis - cells and mediators that activate inflammation -proinflammatory cytokines
IL1 and TNF alpha
Lead to recruitment and activation of other cells
- Influx of inflammatory cells leads to joint damage
- Leads to activation of osteoclast and fibroblasts
- Release metalloproteinases which lead to joint damage
Rheumatoid arthritis - cells and mediators that inhibit inflammation - 5-aminosalicylic acid
Free radical scavenger to decrease damage produce by neutrophils
Rheumatoid arthritis - cells and mediators that inhibit inflammation
Glucocorticoids and ciclosporin
Immunosuppressants - methotrexate
5-aminosalicylic acid
DMARDs
Rheumatoid arthritis - cells and mediators that inhibit inflammation - glucocorticoids and ciclosporin
Inhibit transcription of proinflammatory cytokines
Rheumatoid arthritis - cells and mediators that inhibit inflammation - immunosuppressants - methotrexate
Inhibit induction phase of inflammatory response
Inhibit transcription of immune cells (Th1 which activate macrophages)
Methotrexate – is an antagonist to folic acid which can become a problem
Glucocorticoids and ciclosporin method of action
- Glucocorticoids enter cells and bind to receptors
- Receptors translocate into nucleus and regulate gene transcription
- Ciclosporin block activation of calcineurin
- Cyclophilin binds to calcineurin phosphatase
- Ca binds to calcineurin to activate it
- Calcineurin targets NFkappaB – a transcription factor
- This dephosphorylates NFkappaB which can them move into the nucleus
- From there it controls transcription of genes that promote inflammation
What are biopharmaceuticals? - humanized therapeutic monoclonal antibodies
Humanized therapeutic monoclonal antibodies to target inflammatory mediators
- Neutralize action of soluble or membrane bound proinflammatory cytokines
- FC portion of antibody has got the sequence of the human antibody (not seen as foreign)
What are biopharmaceuticals? - soluble receptor proteins
Soluble receptor proteins for the inflammatory mediators
Bind to cytokine preventing it interacting with its receptor
Asthma affects?
5.4 million in the UK
Causes of asthma
Inflammation of the airways
Bronchial hyper reactivity – sensitised to the triggers
Reversible airway obstruction